FROM MOLECULE...TO HUMAN
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Imaging of Neuro Disease using High Field MR and Contrastophores
The project Inumac (Imaging of Neuro disease Using high field MR and Contrastophores) or Iseult in french, is led by French-German consortium. It is aimed at pushing the frontiers of medical imaging using high field magnetic resonance and novel contrast agents and develops a unique MRI scanner for human imaging operating at 11.7T and its applications.
The project was initiated in 2006 with an overall budget of €200 million, including €80 million in public funding. The project is structured for five years and it involves the University of Freiburg (Germany), Siemens Medical Solutions (Germany), Bruker BioSpin GmbH (Germany), the French Commissariat à l'énergie atomique (CEA, France), Guerbet (France) and Alstom (France).
To develop novel contrast agents (done in June 2012)
At the CEA, this project is a collaboration between:
Strategic pilot: Denis Le BihanOperational pilot: Cécile Lerman
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.